Jefferies Group Reiterates Buy on Body Central Acquisition (BODY)

By admin | 6 years ago

Body Central Acquisition (NASDAQ: BODY)‘s stock had its “buy” rating reiterated by investment analysts at Jefferies Group (NYSE: JEF) in a note issued to investors on Friday.

Body Central Acquisition traded down 0.07% on Friday, hitting $14.92. Body Central Acquisition has a 1-year low of $14.25 and a 1-year high of $30.88. The company has a market cap of $240.6 million and a price-to-earnings ratio of 12.03.

Body Central Acquisition last announced its earnings results on Thursday, May 3rd. The company reported $0.36 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.36. Body Central Acquisition’s revenue was up 11.8% compared to the same quarter last year. Analysts expect that Body Central Acquisition will post $0.23 EPS next quarter.

Several other analysts have also recently commented on the stock. Analysts at William Blair downgraded shares of Body Central Acquisition from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, May 4th. Separately, analysts at Avondale Partners raised their price target on shares of Body Central Acquisition from $34.00 to $37.00 in a research note to investors on Tuesday, May 1st. They now have a “market perform” rating on the stock. Finally, analysts at Piper Jaffray (NYSE: PJC) raised their price target on shares of Body Central Acquisition to $30.00 in a research note to investors on Friday, March 9th.

Body Central Corp. is a specialty retailer of young women’s apparel and accessories operating retail stores in the South, Mid-Atlantic and Midwest regions of the United States.

About the author